Transactions

Ayrmid Pharma’s in-license of rights to APHEXDA® and concurrent investment by Highbridge Capital Management, LLC in BioLineRx Ltd.

Date Announced:
11/21/2024

client:
Ayrmid Pharma

Status:
Closed – 11/21/2024

Value:
Undisclosed